German fragrances maker Symrise AG said on Monday it is in advanced talks to sell its terpenes business and that it would take a non-cash impairment of about 145 million euros ($169.22 million) related to the sale in the fourth quarter.
Sign up here.
“A non-cash impairment in the value of the investment in … Swedencare AB will lead to a material deviation from the expected result for the 2025 financial year compared to current capital market expectations and the published forecast… [1061 chars]
Source: Reuters | Published: 2026-01-12T19:36:15Z
Credit: Reuters
